Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary lateral sclerosis.

Mike A Singer1, Jeffrey M Statland, Gil I Wolfe

  • 1Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8897, USA. mike.singer@utsouthwestern.edu

Muscle & Nerve
|January 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD.

Annals of clinical and translational neurology·2026
Same author

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Muscle & nerve·2026
Same author

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis.

JAMA network open·2026
Same author

Natural history of limb girdle muscular dystrophy R1 (LGMDR1): a GRASP consortium study.

Neuromuscular disorders : NMD·2026
Same author

Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

Neurology. Genetics·2026
Same author

Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup.

Neuromuscular disorders : NMD·2026
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
Same journal

Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

Muscle & nerve·2026
Same journal

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same journal

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
See all related articles

Primary Lateral Sclerosis (PLS) is a rare progressive upper motor neuron disease. Distinguishing PLS from Amyotrophic Lateral Sclerosis (ALS) relies on clinical symptoms, signs, and specific diagnostic criteria.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases

Background:

  • Motor neuron diseases encompass a spectrum of disorders affecting motor neurons.
  • Primary Lateral Sclerosis (PLS) specifically denotes progressive upper motor neuron dysfunction without other identifiable causes.

Purpose of the Study:

  • To review the historical context and current understanding of Primary Lateral Sclerosis (PLS).
  • To delineate the diagnostic criteria and differentiating features of PLS compared to Amyotrophic Lateral Sclerosis (ALS).

Main Methods:

  • Literature review of historical descriptions and major case series of PLS patients.
  • Analysis of diagnostic approaches including laboratory, electrodiagnostic, and imaging studies.
  • Examination of proposed diagnostic criteria for PLS.

Related Experiment Videos

Main Results:

  • Consistent clinical and diagnostic differences exist between PLS and ALS.
  • Ancillary laboratory data, while non-specific, aid in differentiating these conditions.
  • PLS is a distinct clinical entity despite diagnostic challenges.

Conclusions:

  • The clinical designation of PLS remains valuable for identifying a specific upper motor neuron syndrome.
  • Further research into diagnostic criteria and understanding of PLS is warranted.